Yh. Hu et al., Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model, ART THROM V, 21(8), 2001, pp. 1275-1280
Recently, we established a new mouse model of vein graft arteriosclerosis b
y grafting vena cava to carotid arteries. In many respects, the morphologic
al features of this murine vascular graft model resemble those of human ven
ous bypass graft disease. Using this model, we studied the effects of local
gene transfer of tissue inhibitor of metalloproteinase-2 (TIMP-2) on vein
graft remodeling. Mouse isogeneic vessels of the vena caval veins were graf
ted end to end into carotid arteries, then enveloped with the replication-d
efective recombinant adenoviruses overexpressing human TIMP-2 (RAdTIMP-2) o
r beta -galactosidase (RAdLacZ) at 1 x 10(10) plaque-forming units/mL in a
total volume of 50 muL, and incubated at room temperature for 20 minutes. I
n the untreated group, vessel wall thickening was observed as early as I we
ek after surgery and progressed to 4- to 10-fold the original thickness in
grafted veins at 4 and 8 weeks, respectively. RAdLacZ vector treatment sign
ificantly enhanced neointimal lesions at 8 weeks, which was completely bloc
ked by RAdTIMP-2 gene overexpression. Interestingly, RAdTIMP-2 gene transfe
r resulted in a reduction in vessel diameter of grafted veins compared with
ungrafted veins (819 +/- 96 versus 624 +/- 67 mum, respectively; P <0.05).
Maximal beta -galactosidase activity was found at 2 weeks and was detectab
le until 4 weeks after gene transfer. Double immunofluorescence studies dem
onstrated that cells overexpressing TIMP-2 were mostly localized in the adv
entitia and were MAC-1-positive monocytes/macrophages but not smooth muscle
cells. Furthermore, the activity of matrix metalloproteinases was markedly
decreased in the vessel walls treated with RAdTIMP-2 compared with that in
the untreated control group and the RAdLacZ-treated group. Thus, this mous
e model has been proven to be useful in gene transfer studies. Our findings
demonstrate that local TIMP-2 gene transfer significantly reduces vein gra
ft diameter, ie, remodeling, to an artery-like vessel via inhibition of mat
rix metalloproteinase activity.